Foundation Medicine

Foundation Medicine (Roche) is the pioneer and market leader in comprehensive genomic profiling (CGP) for cancer, offering FDA-approved tests including FoundationOne CDx (tissue-based) and FoundationOne Liquid CDx (blood-based) that analyze hundreds of cancer-related genes to identify actionable genetic alterations guiding targeted therapy and immunotherapy selection. The tests serve as FDA-approved companion diagnostics for multiple oncology drugs, enabling oncologists to match patients with the most effective treatments based on their tumor's genomic profile. Used at major cancer centers including Memorial Sloan Kettering, Dana-Farber, and MD Anderson, Foundation Medicine has profiled millions of tumors.